(Q39291196)

10 September 2017

Tumor necrosis factor α stimulates Her-2 cleavage by activated caspase-8. (English)

1 reference

10 September 2017

Xiaojun Li

1

1 reference

10 September 2017

Yang Zhao

2

1 reference

10 September 2017

Yunfeng Zhang

3

1 reference

10 September 2017

Ning Du

4

1 reference

10 September 2017

Hong Ren

5

1 reference

10 September 2017

27 August 2012

1 reference

Cellular Physiology and Biochemistry

10 September 2017

1 reference

10 September 2017

30

1 reference

10 September 2017

4

1 reference

10 September 2017

889-897

1 reference

TNF-alpha induces two distinct caspase-8 activation pathways

10 September 2017

1 reference

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8

21 January 2018

1 reference

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

21 January 2018

1 reference

The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators

21 January 2018

1 reference

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

HER-2/neu gene amplification assessment in breast cancer patients in Isfahan province by real time PCR, differential PCR and immunohistochemistry.

21 January 2018

1 reference

Hints of future progress for HER-2 breast cancer.

21 January 2018

1 reference

Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer

21 January 2018

1 reference

In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.

21 January 2018

1 reference

More than cell death: caspases and caspase inhibitors on the move

21 January 2018

1 reference

Molecular mechanisms of caspase regulation during apoptosis

21 January 2018

1 reference

Death receptor-induced cell killing

21 January 2018

1 reference

The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines

21 January 2018

1 reference

The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1.

21 January 2018

1 reference

Advances in first-line treatment for patients with HER-2+ metastatic breast cancer

21 January 2018

1 reference

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

21 January 2018

1 reference

Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways

21 January 2018

1 reference

Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.

21 January 2018

1 reference

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

21 January 2018

1 reference

A single NFκB system for both canonical and non-canonical signaling

21 January 2018

1 reference

The two faces of NFkappaB in cell survival responses

21 January 2018

1 reference

EMT phenotype is induced by increased Src kinase activity via Src-mediated caspase-8 phosphorylation

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1159/000338489

Identifiers

DOI

10.1159/000341466

1 reference

10 September 2017

1 reference